In order to monitor, evaluate and, where necessary, control the medical and biological activities provided for in 4° of Article L. 1418-1, the Agency shall carry out a quantitative and qualitative analysis of the information it has on these activities and on the techniques used, including therapeutic alternatives to transplantation, as well as an analysis of the results obtained.